English Polski
Vol 20 (2022): Continuous Publishing
Review paper
Published online: 2022-06-20

open access

Page views 1933
Article views/downloads 1708
Get Citation

Connect on Social Media

Connect on Social Media

Erectile dysfunction among male cancer patients

Dariusz Pysz-Waberski1, Joanna Sadurska1, Łukasz Pietrzyński1, Agnieszka Bobola1, Edyta Skwirczyńska2, Iwona Gisterek1
Journal of Sexual and Mental Health 2022;20:49-55.

Abstract

Choroba nowotworowa ma niewątpliwie istotny wpływ na seksualność mężczyzn, niezależnie od ich wieku. Najczęściej występującymi dysfunkcjami seksualnymi związanymi z chorobą onkologiczną są zaburzenia erekcji. Niezdolność do powstania lub utrzymania wzwodu prącia może mieć charakter somatyczny, psychogenny lub mieszany. Stosowanie miejscowego i systemowego leczenia onkologicznego może wpływać na powstawanie lub pogłębianie się dysfunkcji erekcyjnej. Stopień nasilenia zaburzeń i ich wpływ na funkcje seksualne mężczyzn zależą od lokalizacji i stopnia zaawansowania nowotworu oraz stosowanych metod leczenia. Odpowiednia komunikacja z pacjentem onkologicznym w zakresie seksualności jest kluczowa w celu prawidłowego rozpoznania i leczenia wtórnych zaburzeń erekcji. Ustawiczne szkolenie kadr medycznych, również w zakresie zdrowia seksualnego, wydaje się nieodzowne w wielodyscyplinarnym podejściu do leczenia pacjentów onkologicznych. Wsparcie zespołu onkologicznego przez psychoonkologówekspertów w zakresie zdrowia psychicznego oraz seksualnego — staje się standardem opieki onkologicznej w renomowanych ośrodkach onkologicznych na świecie.

Leczenie zaburzeń erekcji jest wieloetapowe. W pierwszej kolejności stosuje się psychoterapię, później farmakoterapię. Brak zadowalających efektów tych metod skłania do korzystania z metod mechanicznych (aparaty próżniowe) oraz zabiegowych (iniekcje do ciał jamistych, zabiegi chirurgiczne).

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Carter J, Lacchetti C, Andersen BL, et al. Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. J Clin Oncol. 2018; 36(5): 492–511.
  2. Pysz-Waberski D. Psychoonkologia praktyczna. CRP, Wrocław 2018: 93–98.
  3. Madan R, Dracham CB, Khosla D, et al. Erectile dysfunction and cancer: current perspective. Radiat Oncol J. 2020; 38(4): 217–225.
  4. Kouidrat Y, Pizzol D, Cosco T, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017; 34(9): 1185–1192.
  5. Esposito K, Giugliano D, Esposito K, et al. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res. 2005; 17(5): 391–398.
  6. Javaroni V, Neves MF. Erectile dysfunction and hypertension: impact on cardiovascular risk and treatment. Int J Hypertens. 2012; 2012: 627278.
  7. Konukoglu D, Uzun H. Endothelial Dysfunction and Hypertension. Adv Exp Med Biol. 2017; 956: 511–540.
  8. Schover LR. Managing erectile dysfunction after cancer: more than penile rigidity. J Oncol Pract. 2016; 12(4): 307–308.
  9. Schover LR, van der Kaaij M, van Dorst E, et al. Sexual dysfunction and infertility as late effects of cancer treatment. EJC Suppl. 2014; 12(1): 41–53.
  10. Lima TF, Bitran J, Frech FS, et al. Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities. Int J Impot Res. 2021; 33(4): 401–409.
  11. Carter J, Lacchetti C, Andersen BL, et al. Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. J Clin Oncol. 2018; 36(5): 492–511.
  12. Sörensson M, Asplund D, Matthiessen P, et al. Self-reported sexual dysfunction in patients with rectal cancer. Colorectal Dis. 2020; 22(5): 500–512.
  13. Bond CB, Jensen PT, Groenvold M, et al. Prevalence and possible predictors of sexual dysfunction and self-reported needs related to the sexual life of advanced cancer patients. Acta Oncol. 2019; 58(5): 769–775.
  14. Nelson CJ, Mulhall JP, Roth AJ. The association between erectile dysfunction and depressive symptoms in men treated for prostate cancer. J Sex Med. 2011; 8(2): 560–566.
  15. Akyol M, Ulger E, Alacacioglu A, et al. Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients [Izmir Oncology Group (IZOG) study]. Jpn J Clin Oncol. 2015; 45(7): 657–664.
  16. Pühse G, Wachsmuth JU, Kemper S, et al. Chronic pain has a negative impact on sexuality in testis cancer survivors. J Androl. 2012; 33(5): 886–893.
  17. Seklehner S, Hladschik-Kermer B, Lusuardi L, et al. Psychological stress assessment of patients suffering from prostate cancer. Scand J Urol. 2013; 47(2): 101–107.
  18. Köhler N, Friedrich M, Gansera L, et al. Psychological distress and adjustment to disease in patients before and after radical prostatectomy. Results of a prospective multi-centre study. Eur J Cancer Care (Engl). 2014; 23(6): 795–802.
  19. Albaugh JA, Sufrin N, Lapin BR, et al. Life after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners. BMC Urol. 2017; 17(1): 45.
  20. Voznesensky M, Annam K, Kreder KJ. Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer. J Oncol Pract. 2016; 12(4): 297–304.
  21. Wiechno P, Demkow T, Kubiak K, et al. The quality of life and hormonal disturbances in testicular cancer survivors in Cisplatin era. Eur Urol. 2007; 52(5): 1448–1454.
  22. Snyder KM, Stock RG, Buckstein M, et al. Long-term potency preservation following brachytherapy for prostate cancer. BJU Int. 2012; 110(2): 221–225.
  23. Siglin J, Kubicek GJ, Leiby B, et al. Time of decline in sexual function after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010; 76(1): 31–35.
  24. Nolan MW, Marolf AJ, Ehrhart EJ, et al. Pudendal nerve and internal pudendal artery damage may contribute to radiation-induced erectile dysfunction. Int J Radiat Oncol Biol Phys. 2015; 91(4): 796–806.
  25. Kimura M, Zodda AR, Mahmood J, et al. Pilot Study Evaluating a Rat Model of Radiation-induced Erectile Dysfunction Using an Image-guided Microirradiator. Urology. 2015; 85(5): 1214.e1–1214.e6.
  26. Rivin del Campo E, Thomas K, Weinberg V, et al. Erectile dysfunction after radiotherapy for prostate cancer: a model assessing the conflicting literature on dose-volume effects. Int J Impot Res. 2013; 25(5): 161–165.
  27. Yildirim HC, Ergen SA, Sedef E, et al. Erectile dysfunction in prostate cancer patients treated with intensity-modulated radiation therapy. Indian J Cancer. 2020; 57(1): 70–75.
  28. Johansson E, Steineck G, Holmberg L, et al. SPCG-4 Investigators. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011; 12(9): 891–899.
  29. Nelson CJ, Scardino PT, Eastham JA, et al. Back to baseline: erectile function recovery after radical prostatectomy from the patients' perspective. J Sex Med. 2013; 10(6): 1636–1643.
  30. Hatzichristodoulou G, Wagenpfeil S, Wagenpfeil G, et al. Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis. World J Urol. 2016; 34(6): 811–820.
  31. Pizzol D, Xiao T, Smith L, et al. Prevalence of erectile dysfunction in male survivors of cancer: a systematic review and meta-analysis of cross-sectional studies. Br J Gen Pract. 2021; 71(706): e372–e380.
  32. Costa P, Cardoso JM, Louro H, et al. Impact on sexual function of surgical treatment in rectal cancer. Int Braz J Urol. 2018; 44(1): 141–149.
  33. Tsikis ST, Nottingham CU, Faris SF. The Relationship Between Incontinence and Erectile Dysfunction After Robotic Prostatectomy: Are They Mutually Exclusive? J Sex Med. 2017; 14(10): 1241–1247.
  34. Trofimenko V, Myers JB, Brant WO. Post-Prostatectomy Incontinence: How Common and Bothersome Is It Really. Sex Med Rev. 2017; 5(4): 536–543.
  35. Wallis CJD, Mahar A, Cheung P, et al. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study. Lancet Oncol. 2014; 15(2): 223–231.
  36. Pallotti F, Petrozzi A, Cargnelutti F, et al. Long-Term Follow Up of the Erectile Function of Testicular Cancer Survivors. Front Endocrinol (Lausanne). 2019; 10: 196.
  37. Mohamed NE, Chaoprang Herrera P, Hudson S, et al. Muscle invasive bladder cancer: examining survivor burden and unmet needs. J Urol. 2014; 191(1): 48–53.
  38. Modh RA, Mulhall JP, Gilbert SM. Sexual dysfunction after cystectomy and urinary diversion. Nat Rev Urol. 2014; 11(8): 445–453.
  39. Fainberg J, Gaffney CD, Pierce H, et al. Erectile Dysfunction is a Transient Complication of Prostate Biopsy: A Systematic Review and Meta-Analysis. J Urol. 2021; 205(3): 664–670.
  40. Albaugh JA, Tenfelde S, Hayden DM. Sexual Dysfunction and Intimacy for Ostomates. Clin Colon Rectal Surg. 2017; 30(3): 201–206.
  41. Arden-Close E, Eiser C, Pacey A. Sexual functioning in male survivors of lymphoma: a systematic review (CME). J Sex Med. 2011; 8(7): 1833–1841.
  42. Hung MS, Chen YC, Huang TY, et al. Erectile Dysfunction After Surgical Treatment of Lung Cancer: Real-World Evidence. Clin Epidemiol. 2020; 12: 977–987.
  43. Jakima S. Dysfunkcje seksualne. Poradnik dla lekarzy. PZWL Wydawnictwo Lekarskie, Warszawa 2019: 108–122.
  44. Lew-Starowicz M, Lew-Starowicz Z, Skrzypulec-Plinta V. Seksuologia. PZWL Wydawnictwo Lekarskie, Warszawa 2018: 260–275.
  45. Sipiński A. Zaburzenia erekcji. In: Lew-Starowicz Z, Skrzypulec V. ed. Seksuologia. PZWL Wydawnictwo Lekarskie, Warszawa : 181–185.
  46. Carter J, Lacchetti C, Andersen BL, et al. Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. J Clin Oncol. 2018; 36(5): 492–511.
  47. Depko A. Fizjologia reakcji seksualnej mężczyzn. In: Lew-Starowicz ZA, Skrzypulec V. ed. Podstawy seksuologii. PZWL Wydawnictwo Lekarskie, Warszawa 2015: 111–122.
  48. Freyberger HJ, Schneider W, Rolf-Dieter S. Kompendium Psychiatrii, Psychoterapii, Medycyny psychosomatycznej. PZWL, Warszawa 2015.
  49. Emanu JC, Avildsen IK, Nelson CJ. Erectile dysfunction after radical prostatectomy: prevalence, medical treatments, and psychosocial interventions. Curr Opin Support Palliat Care. 2016; 10(1): 102–107.
  50. Simopoulos EF, Trinidad AC. Male erectile dysfunction: integrating psychopharmacology and psychotherapy. Gen Hosp Psychiatry. 2013; 35(1): 33–38.
  51. Melnik T, Soares BGO, Nasello AG. The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices. J Sex Med. 2008; 5(11): 2562–2574.



Journal of Sexual and Mental Health